/Companies

Xylo

Sydney, AU · 33 employees on LinkedIn · 9 known investors

Find your way into Xylo

Sign up to see every warm intro you have to Xylo

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Xylo team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches. The company serves patients and healthcare systems seeking novel treatments for complex neuropsychiatric conditions.

Founders & leadership

JI
Joshua IsminCo-founder, PresidentInvestor at AirTree Ventures
DS
Dr. Sam BanisterCo-founder, Chief Scientific Officer

Investors · 9

Also in the syndicate · 2

Endurance VenturesTiny VC

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Xylo do?
Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches. The company serves patients and healthcare systems seeking novel treatments for complex neuropsychiatric conditions.
Who founded Xylo?
Xylo was founded by Joshua Ismin, Dr. Sam Banister.
Who are Xylo's investors?
Xylo's investors include Palo Santo VC, Radar Ventures, Tenmile, XEIA Venture Partners, CapitalT, Common Magic, Sure Valley Ventures.
Where is Xylo headquartered?
Xylo is headquartered in Sydney, AU.